Exhaustive CoMFA and CoMSIA analyses around different chemical entities: a ligand-based study exploring the affinity and selectivity profiles of 5-HT_1A ligands

References

• Hannon J, Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res 2008;195:198–213.
   PubMed Web of Science ®Google Scholar
• Yocca FD, Hyslop DK, Smith DW, Maayani S. BMY 7378, a buspirone analog with high affinity, selectivity and low intrinsic activity at the 5-HT1A receptor in rat and guinea pig hippocampal membranes. Eur J Pharmacol 1987;137:293–4.
   PubMed Web of Science ®Google Scholar
• Olivier B, Soudijn W, van Wijngaarden I. The 5-HT1A receptor and its ligands: structure and function. Prog Drug Res 1999;52:103–65.
   PubMedGoogle Scholar
• Gonzalez LE, File SE, Overstreet DH. Selectively bred lines of rats differ in social interaction and hippocampal 5-HT1A receptor function: a link between anxiety and depression? Pharmacol Biochem Behav 1998;59:787–92.
   PubMed Web of Science ®Google Scholar
• Gurwitz D. Novel 5-HT-receptor agonists: F11440, MKC242 and BAYx3702. Drug Discov Today 1999;4:142–3.
   PubMed Web of Science ®Google Scholar
• Schechter LE, Smith DL, Rosenzweig-Lipson S, et al. Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties. J Pharm Exp Ther 2005;314:1274–89.
   PubMed Web of Science ®Google Scholar
• Fiorino F, Severino B, Magli E, et al. 5-HT(1A) receptor: an old target as a new attractive tool in drug discovery from central nervous system to cancer. J Med Chem 2014;57:4407–26.
   PubMed Web of Science ®Google Scholar
• Patane MA, DiPardo RM, Price RP, et al. Selective alpha-1a adrenergic receptor antagonists. Effects of pharmacophore regio- and stereochemistry on potency and selectivity. Bioorg Med Chem Lett 1998;8:2495–500.
   PubMed Web of Science ®Google Scholar
• Brasili L, Sorbi C, Franchini S, et al. 1,3-Dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists. J Med Chem 2013;46:1504–11.
   Web of Science ®Google Scholar
• Sorbi C, Franchini S, Tait A, et al. 1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationship at α1- and 5-HT1A receptors. ChemMedChem 2009;4:393–9.
   PubMed Web of Science ®Google Scholar
• Franchini S, Tait A, Prandi A, et al. (2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine a new potent and selective 5-HT1A receptor agonist. ChemMedChem 2009;4:196–203.
   PubMed Web of Science ®Google Scholar
• Franchini S, Prandi A, Baraldi A, et al. 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors. Eur J Med Chem 2010;45:3740–51.
   PubMed Web of Science ®Google Scholar
• Franchini S, Prandi A, Sorbi C, et al. Discovery of a new series of 5-HT1A receptor agonists. Bioorg Med Chem Lett 2010;20:2017–20.
   PubMed Web of Science ®Google Scholar
• Prandi A, Franchini S, Manasieva LI, et al. Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α- and serotonine 5-HT1A receptors. J Med Chem 2012;55:23–36.
   PubMed Web of Science ®Google Scholar
• Franchini S, Battisti UM, Baraldi A, et al. Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors. Eur J Med Chem 2014;87:248–66.
   PubMed Web of Science ®Google Scholar
• Guariento S, Bruno O, Fossa P, Cichero E. New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies. Mol Divers 2016;20:77–92.
   PubMed Web of Science ®Google Scholar
• Cichero E, Buffa L, Fossa P. 3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses. J Mol Model 2011;7:1537–50.
   Web of Science ®Google Scholar
• Cichero E, Cesarini S, Mosti L, Fossa P. CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonists. J Mol Model 2010;16:1481–98.
   PubMed Web of Science ®Google Scholar
• Cichero E, Cesarini S, Mosti L, Fossa P. CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists. J Mol Model 2010;16:677–91.
   PubMed Web of Science ®Google Scholar
• Mella-Raipán J, Hernández-Pino S, Morales-Verdejo C, Pessoa-Mahana D. 3D-QSAR/CoMFA-based structure-affinity/selectivity relationships of aminoalkylindoles in the cannabinoid CB1 and CB2 receptors. Molecules 2014;19:2842–61.
   PubMed Web of Science ®Google Scholar
• Cichero E, Brullo C, Bruno O, Fossa P. Exhaustive 3D-QSAR analyses as a computational tool to explore the potency and selectivity profiles of thieno[3,2-d]pyrimidin-4(3H)-one derivatives as PDE7 inhibitors. RSC Adv 2016;6:61088–108.
   Web of Science ®Google Scholar
• Mei D, Yin Y, Wua F, et al. Discovery of potent and selective urea-based ROCK inhibitors: exploring the inhibitor’s potency and ROCK2/PKA selectivity by 3D-QSAR, molecular docking and molecular dynamics simulations. Bioorg Med Chem 2015;23:2505–17.
   PubMed Web of Science ®Google Scholar
• MOE: Chemical Computing Group Inc. Montreal. H3A 2R7 Canada. Available from: www.chemcomp.com.
   Google Scholar
• Franchini S, Baraldi A, Sorbi C, et al. Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α1 and 5-HT1A receptor ligand: an in vitro and computational study. Med Chem Commun 2015;6:677–90.
   Web of Science ®Google Scholar
• Cramer IIIRD, Patterson DE, Bunce JD. Comparative Molecular Field Analysis (CoMFA). Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 1988;110:5959–67.
   PubMed Web of Science ®Google Scholar
• Klebe G, Abraham U, Mietzner T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 1994;37:4130–46.
   PubMed Web of Science ®Google Scholar
• Sybyl-X 1.0. Tripos Inc. 1699 South Hanley Road, St Louis, Missouri 63144, USA.
   Google Scholar
• Cichero E, Cesarini S, Fossa P, et al. Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses. Eur J Med Chem 2009;44:2059–70.
   PubMed Web of Science ®Google Scholar
• Cichero E, Cesarini S, Fossa P, et al. Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses. J Mol Model 2009;15:871–84.
   PubMed Web of Science ®Google Scholar
• Cichero E, Bruno O, Fossa P. Docking-based CoMFA and CoMSIA analyses of tetrahydro-β-carboline derivatives as type-5 phosphodiesterase inhibitors. J Enzyme Inhib Med Chem 2011;27:730–43.
   PubMed Web of Science ®Google Scholar
• Partyka A, Chłoń-Rzepa G, Wasik A, et al. Antidepressant- and anxiolytic-like activity of 7-phenylpiperazinylalkyl-1,3-dimethyl-purine-2,6-dione derivatives with diversified 5-HT1A receptor functional profile. Bioorg Med Chem 2015;23:212–21.
   PubMed Web of Science ®Google Scholar